Daniel C. Scullin
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 15
- Lung Cancer Research Studies 7
- Pancreatic and Hepatic Oncology Research 3
- CAR-T cell therapy research 2
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- John D. Hainsworth (14 shared papers)Howard A. Burris (12 shared papers)F. Anthony Greco (13 shared papers)Lisa H. Morrissey (8 shared papers)Sharlene Litchy (5 shared papers)Paul Richards (3 shared papers)James D. Bearden (3 shared papers)Denise A. Yardley (5 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (3 papers)CHEST Journal (3 papers)Blood (2 papers)Cancer Investigation (2 papers)
- Partner nations
- United States
In The Last Decade
Daniel C. Scullin
20 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 46
- Pathology and Forensic Medicine 650
- Genetics 362
- Oncology 586
- Oral Surgery 97
- Radiology, Nuclear Medicine and Imaging 233
Countries citing papers authored by Daniel C. Scullin
This map shows the geographic impact of Daniel C. Scullin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Scullin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Scullin more than expected).
Fields of papers citing papers by Daniel C. Scullin
This network shows the impact of papers produced by Daniel C. Scullin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Scullin. The network helps show where Daniel C. Scullin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel C. Scullin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 321 | |
| 2 | 2000 | 200 | |
| 3 | 2000 | 182 | |
| 4 | 2002 | 85 | |
| 5 | 1979 | 43 | |
| 6 | 2001 | 38 | |
| 7 | 1999 | 35 | |
| 8 | 2002 | 25 | |
| 9 | 2005 | 25 | |
| 10 | 1991 | 20 | |
| 11 | 2003 | 19 | |
| 12 | 1991 | 15 | |
| 13 | Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer. | 2000 | 12 |
| 14 | 1979 | 11 | |
| 15 | 2002 | 7 | |
| 16 | 2004 | 6 | |
| 17 | 2004 | 3 | |
| 18 | 2022 | 1 | |
| 19 | 2005 | 1 | |
| 20 | 2020 | 1 |
About Daniel C. Scullin
Daniel C. Scullin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Epidemiology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer therapeutics and mechanisms (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (650 citations), Genetics (362 citations), Oncology (586 citations), Oral Surgery (97 citations) and Radiology, Nuclear Medicine and Imaging (233 citations). Daniel C. Scullin has collaborated with scholars based in United States. Frequent co-authors include John D. Hainsworth, Howard A. Burris, F. Anthony Greco, Lisa H. Morrissey, Sharlene Litchy, Paul Richards, James D. Bearden, Denise A. Yardley, Steven Corso and Harvey Jay Cohen. Their work appears in journals such as Journal of Clinical Oncology, Cancer, CHEST Journal, Blood and Cancer Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.